Coexistent hereditary and inflammatory neuropathy

Brain

Volumn 127, Issue 1, 2004, Pages 193-202

  Ginsberg, Lionel ^a,b   Malik, Omar ^b   Kenton, Anthony R ^d   Sharp, David ^b   Muddle, John R ^b   Davis, Mary B ^c   Winer, John B ^d   Orrell, Richard W ^a,b   King, Rosalind H M ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Charcot Marie Tooth disease; Chronic inflammatory demyelinating polyneuropathy; Nerve biopsy; Neuropathy; Peripheral nerve

Indexed keywords

IMMUNOGLOBULIN; STEROID;

ADULT; AGED; ARTICLE; CHROMOSOME 17P; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; ELECTROPHYSIOLOGY; FAMILY HISTORY; FEMALE; GENE; GENE MUTATION; GENETIC PREDISPOSITION; GENOTYPE; GJB1 GENE; HEREDITARY MOTOR SENSORY NEUROPATHY; HEREDITY; HUMAN; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; MALE; NERVE BIOPSY; NEUROPATHOLOGY; PATHOGENESIS; PRIORITY JOURNAL; TREATMENT OUTCOME; X CHROMOSOME LINKED DISORDER;

EID: 0346097880     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awh017     Document Type: Article

References (45)

1. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for the diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991; 41: 617-8.
2. Balice-Gordon RJ, Bone LJ, Scherer SS. Functional gap junctions in the Schwann cell myelin sheath. J Cell Biol 1998; 142: 1095-104.
3. Bergoffen J, Scherer SS, Wang S, Scott MO, Bone LJ, Paul DL, et al. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 1993; 262: 2039-42.
4. Bird SJ, Sladky JT. Corticosteroid-responsive dominantly inherited neuropathy in childhood. Neurology 1991; 41: 437-9.
5. Boerkoel CF, Takashima H, Garcia CA, Olney RK, Johnson J, Berry K, et al. Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation. Ann Neurol 2002: 51: 190-201.
6. Bruzzone R, White TW, Paul DL. Connections with connexins: the molecular basis of direct intercellular signaling. Eur J Biochem 1996; 238: 1-27.
7. Chad DA, Smith TW, DeGirolami U, Hammer K. Perineuritis and ulcerative colitis. Neurology 1986; 36: 1377-9.
8. D'Urso D, Brophy PJ, Staugaitis SM, Gillespie CS, Frey AB, Stempak JG, et al. Protein zero of peripheral nerve myelin: biosynthesis, membrane insertion, and evidence for homotypic interaction. Neuron 1990; 4: 449-60.
9. D'Urso D, Ehrhardt P, Muller HW. Peripheral myelin protein 22 and protein zero: a novel association in peripheral nervous system myelin. J Neurosci 1999; 19: 3396-403.
10. Donaghy M, Sisodiya SM, Kennett R, McDonald B, Haites N, Bell C. Steroid responsive polyneuropathy in a family with a novel myelin protein zero mutation. J Neurol Neurosurg Psychiatry 2000; 69: 799-805.
11. Dyck PJ, Swanson CJ, Low PA, Bartleson JD, Lambert EH. Prednisone-responsive hereditary motor and sensory neuropathy. Mayo Clin Proc 1982; 57: 239-46.
12. Fairweather N, Bell C, Cochrane S, Chelly J, Wang S, Mostacciuolo ML, et al. Mutations in the connexin 32 gene in X-linked dominant Charcot-Marie-Tooth disease (CMTX1). Hum Mol Genet 1994; 3: 29-34.
13. Filbin MT, Walsh FS, Trapp BD, Pizzey JA, Tennekoon GI. Role of myelin P0 protein as a homophilic adhesion molecule. Nature 1990; 344: 871-2.
14. Fitzsimons RB. Facioscapulohumeral dystrophy: the role of inflammation. Lancet 1994; 344: 902-3.
15. Gabreels-Festen AA, Gabreels FJ, Hoogendijk JE, Bolhuis PA, Jongen PJ, Vingerhoets HM. Chronic inflammatory demyelinating polyneuropathy or hereditary motor and sensory neuropathy? Diagnostic value of morphological criteria. Acta Neuropathol (Berl) 1993; 86: 630-5.
16. Gabriel CM, Hughes RAC, Moore SE, Smith KJ, Walsh FS. Induction of experimental autoimmune neuritis with peripheral myelin protein-22. Brain 1998; 121: 1895-902.
17. Gabriel CM, Gregson NA, Hughes RAC. Anti-PMP22 antibodies in patients with inflammatory neuropathy. J Neuroimmunol 2000; 104: 139-46.
18. Gabriel CM, Gregson NA, Wood NW, Hughes RAC. Immunological study of hereditary motor and sensory neuropathy type 1a (HMSN1a). J Neurol Neurosurg Psychiatry 2002; 72: 230-5.
19. Ginsberg L. Complex familial neuropathy. In: Schapira AHV, Rowland LP, editors. Clinical cases in neurology. Oxford: Butterworth-Heinemann; 2001. p. 247-53.
20. Gutierrez A, England JD, Sumner AJ, Ferer S, Warner LE, Lupski JR, et al. Unusual electrophysiological findings in X-linked dominant Charcot-Marie-Tooth disease. Muscle Nerve 2000; 23: 182-8.
21. Harding AE, Thomas PK. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 1980; 103: 259-80.
22. Inherited Peripheral Neuropathies Mutation Database online. http://molgen-www.uia.ac.be/CMTmutations/ [26 August 2003].
23. Lewis RA, Sumner AJ. The electrodiagnostic distinctions between chronic familial and acquired demyelinative neuropathies. Neurology 1982; 32: 592-6.
24. Lilje O. The processing and presentation of endogenous and exogenous antigen by Schwann cells in vitro. Cell Mol Life Sci 2002; 59: 2191-8.
25. Lunn MP, Manji H, Choudhary PP, Hughes RA, Thomas PK. Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England. J Neurol Neurosurg Psychiatry 1999; 66: 677-80.
26. Lupski JR, de Oca-Luna RM, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, et al. DNA duplication associated with Charcot-Marie-Tooth disease type IA. Cell 1991; 66: 219-32.
27. Malik O, Sharp D, King RHM, Orrell R, Ginsberg L. Coexistent hereditary and inflammatory neuropathy [abstract]. J Neurol Neurosurg Psychiatry 2000; 69: 415.
28. Matsunami N, Smith B, Ballard L, Lensch MW, Robertson M, Albertson H, et al. Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A. Nat Genet 1992; 1: 176-9.
29. Nicholson G, Nash J. Intermediate nerve conduction velocities define X-linked Charcot-Marie-Tooth neuropathy families. Neurology 1993; 43: 2558-64.
30. Patel PI, Roa BB, Welcher AA, Schoener-Scott R, Trask BJ, Pentao L, et al. The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nat Genet 1992; 1: 159-65.
31. Prensky AL, Dodson WE. The steroid treatment of hereditary motor and sensory neuropathy. Neuropediatrics 1984; 15: 203-7.
32. Raeymaekers P. Timmerman V, Nelis E, De Jonghe P, Hoogendijk JE, Baas F, et al. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group. Neuromuscul Disord 1991; 1: 93-7.
33. Ritz MF, Lechner-Scott J, Scott RJ, Fuhr P, Malik N, Erne B, et al. Characterisation of autoantibodies to peripheral myelin protein 22 in patients with hereditary and acquired neuropathies. J Neuroimmunol 2000; 104: 155-63.
34. Schaumburg HH, Powers JM, Raine CS, Suzuki K, Richardson EP Jr. Adrenoleukodystrophy. A clinical and pathological study of 17 cases. Arch Neurol 1975; 32: 577-91.
35. Schmid CD, Stienekemeier M, Oehen S, Bootz F, Zielasek J, Gold R, et al. Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance. J Neurosci 2000; 20: 729-35.
36. Schmidt B, Toyka KV, Kiefer R, Full J, Hartung HP, Pollard J. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating neuropathy. Muscle Nerve 1996; 19: 474-87.
37. Sievers J. Basic two-dye stains for epoxy-embedded 0.3-1μ sections. Stain Technol 1971; 46: 195-9.
38. Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin Genet 1974; 6: 98-118.
39. Tabaraud F, Lagrange E, Sindou P, Vandenberghe A, Levy N, Vallat JM. Demyelinating X-linked Charcot-Marie-Tooth disease: unusual electrophysiological findings. Muscle Nerve 1999; 22: 1442-7.
40. Thomas PK, Lascelles RG, Stewart G. Hypertrophic neuropathy. In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology, Vol. 21. Amsterdam: Elsevier; 1975. p. 145-70.
41. Thomas PK, Marques W Jr, Davis MB, Sweeney MG, King RHM, Bradley JL, et al. The phenotypic manifestations of chromosome 17p11.2 duplication. Brain 1997; 120: 465-78.
42. Timmerman V, Nelis E, Van Hul W, Nieuwenhuijsen BW, Chen KL, Wang S, et al. The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nat Genet 1992; 1: 171-5.
43. Valentijn LJ, Bolhuis PA, Zorn I, Hoogendijk JE, van den Bosch N, Hensels GW, et al. The peripheral myelin gene PMP-22/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A. Nat Genet 1992; 1: 166-70.
44. Vallat JM, Tabaraud F, Magy L, Torny F, Bernet-Bernady P, Macian F, et al. Diagnostic value of nerve biopsy for atypical chronic inflammatory demyelinating polyneuropathy: evaluation of eight cases. Muscle Nerve 2003; 27: 478-85.
45. Watanabe M, Yamamoto N, Ohkoshi N, Nagata H, Kohno Y, Hayashi A, et al. Corticosteroid-responsive asymmetric neuropathy with a myelin protein zero gene mutation. Neurology 2002; 59: 767-9.